HEPSA

Your search returned 35 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Hepatitis C virus reinfection risk after successful therapy in HIV-positive patients by New York Infectious Disease Advisor 2022
Online resources:
Availability: Items available for loan: Library (1).
2.
Broad access to Direct-Acting Antivirals reduces HCV reinfections in patients with HIV by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2024
Online resources:
Availability: Items available for loan: Library (1).
3.
What Is the estimated global prevalence of hepatitis C by 2030? by New York Infectious Disease Advisor 2022
Online resources:
Availability: Items available for loan: Library (1).
4.
Hepatitis C in patients with HIV increases age-related cardiovascular disease risk by New York Infectious Disease Advisor 2022
Online resources:
Availability: Items available for loan: Library (1).
5.
COVID 19 case studies: hepatitis. peripheral ischemia, and pulmonary embolism by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2021
Online resources:
Availability: Items available for loan: Library (1).
6.
Opioid Agonist Therapy linked to increased HCV treatment rates in people who inject drugs by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2021
Online resources:
Availability: Items available for loan: Library (1).
7.
Universal screening for hepatitis B virus offers better health outcomes, cost savings by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2021
Online resources:
Availability: Items available for loan: Library (1).
8.
9.
Cocaine use and hepatitis C infection: what’s the link? by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2020
Online resources:
Availability: Items available for loan: Library (1).
10.
Viral hepatitis and psychiatric disorders in adults, youths by Series: Infectious Disease AdvisorInfectious Disease Advisor New York 2019
Online resources:
Availability: Items available for loan: Library (1).
11.
Changes in adaptive B cell response in infants exposed, uninfected with HCV by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2020
Online resources:
Availability: Items available for loan: Library (1).
12.
Small case series describes clinical course of patients with COVID-19 and chronic HBV by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2020
Online resources:
Availability: Items available for loan: Library (1).
13.
In DAA-treated chronic HCV, older age associated with increased comorbidities Infectious by New York Infectious Disease Advisor 2020
Online resources:
Availability: Items available for loan: Library (1).
14.
HCV treatment response high regardless of recent injection drug use by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1)Call number: 3.1.
15.
Low cost needle and syringe programs reduce HCV transmission effectively by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1)Call number: 2.4.
16.
Challenges in preventing mother-to-child transmission of hepatitis C virus by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1)Call number: 7.1.
17.
Early antiviral therapy reduces HBsAg in infantile hepatitis B infection by Series: Hepatitis AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1).
18.
Local and international transmission trends of hepatitis C virus in MSM by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1).
19.
Drug and alcohol behaviors with direct-acting antiviral treatment in HCV by Series: Hepatitis AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1).
20.
Outcomes of feasibilty study on DAAs in injection drug users by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1).
Pages

Powered by

Koha

Provided by

Hepatitis SA

Hosted by

Catalyst

Hepatitis SA acknowledges and respects the Kaurna people as the traditional custodians of the unceded ancestral land from which we work. We pay our respects to elders past and present.